Clinical Trial Update: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of PANVAC-V and PANVAC-F vaccines with sargramostim in advanced cancers (adenocarcinoma, colorectal cancer; other listed conditions) completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Breast Cancer
• Colorectal Cancer
• Ovarian Cancer

Drugs mentioned

• PANVAC-F
• PANVAC-V
• sargramostim (sargramostim)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-16